ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

An Immune-Modulatory Strategy to Mitigate Hepatic Ischemia Reperfusion/Injury in a Murine Model

A. Kobayashi1, A. Wanchoo2, J. Simonovich2, S. Duarte1, V. Boominathan1, S. Shrestha1, G. Hudalla2, B. Keselowsky2

1Surgery, University of Florida, Gainesville, FL, 2Biomedical Engineering, University of Florida, Gainesville, FL

Meeting: 2020 American Transplant Congress

Abstract number: B-352

Keywords: Ischemia, Liver

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session B: Ischemia Reperfusion & Organ Rehabilitation

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Nanodiamond-Doxorubicin Complexes Improve Hepatic Ischemia/Reperfusion Injury
  • Hydrogen Sulfide Supplementation Helps Mitigate Effects of Ischemia Reperfusion Injury in a Murine Model of Donation After Cardiac Death Renal Transplantation.

*Purpose: Hepatic ischemia/reperfusion injury (IRI) is the leading cause of early graft dysfunction and contributes to the shortage of donor organs. However, despite its obvious clinical importance, there are no effective therapies to prevent or treat this condition. Indoleamine 2,3-dioxygenase (IDO) is an intracellular enzyme that catalyzes the catabolism of the essential amino acid tryptophan to the product kynurenine. It is well known for inducing a powerful immunosuppressive metabolic programming. To date, studies have mostly focused on prolonging graft survival by overexpressing IDO in the transplanted tissue. PEGylation of therapeutic proteins reduces their immunogenicity and extends their time in the systemic circulation, therefore improving their efficacy. Here, we PEGylate IDO and test the efficacy of this targeted IDO delivery strategy to control the local hepatic inflammatory response in a mouse model of warm liver IRI.

*Methods: To achieve this, we used a well-establishedmouse model of partial hepatic ischemia reperfusion injury. Partial hepatic ischemia was produced in the left and median lobes for 90 minutes followed by 6 hours reperfusion. Male 8-12 week old Balb/c mice were separated into 3 cohorts: PEGylated-IDO (PEG-IDO), IDO and phosphate buffered saline were intravenously administered 48 hours prior to inducing ischemic injury.

*Results: IDO PEGylation significantly improved hepatic Ischemia reperfusion injury; plasma levels of aspartate alanine aminotransferase at 6 hours after reperfusion were significantly lower in the PEG-IDO group, when compared with those in PBS group (P=0.008). Histological analysis showed significantly less congestion, necrosis, and vacuolization in the PEG-IDO group compared with those in PBS groups (P<0.001) as assessed by Suzuki score. Furthermore, while control mice demonstrated a marked increase in the infiltration of activated inflammatory leukocytes, these were significantly reduced in the livers of mice administered PEGylated-IDO.

*Conclusions: The results in this study indicate that PEG-IDO preconditioning protects livers from the uncontrolled development of warm hepatic IRI. We suggest that this immune-modulatory approach may be clinically useful as a protective measure against liver IRI.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kobayashi A, Wanchoo A, Simonovich J, Duarte S, Boominathan V, Shrestha S, Hudalla G, Keselowsky B. An Immune-Modulatory Strategy to Mitigate Hepatic Ischemia Reperfusion/Injury in a Murine Model [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/an-immune-modulatory-strategy-to-mitigate-hepatic-ischemia-reperfusion-injury-in-a-murine-model/. Accessed March 8, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.